1. Home
  2. PRAX vs MMYT Comparison

PRAX vs MMYT Comparison

Compare PRAX & MMYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$303.20

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

HOLD

Current Price

$45.76

Market Cap

5.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
MMYT
Founded
2015
2000
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
5.3B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
PRAX
MMYT
Price
$303.20
$45.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
3
Target Price
$572.13
$106.33
AVG Volume (30 Days)
317.3K
1.3M
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6,395.88
$17.72
P/E Ratio
N/A
$107.67
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$45.04
52 Week High
$354.87
$113.85

Technical Indicators

Market Signals
Indicator
PRAX
MMYT
Relative Strength Index (RSI) 43.67 28.34
Support Level $290.36 N/A
Resistance Level $322.32 $103.73
Average True Range (ATR) 16.98 2.25
MACD -4.53 -0.35
Stochastic Oscillator 22.60 6.32

Price Performance

Historical Comparison
PRAX
MMYT

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

Share on Social Networks: